Page 18 - Information Document News Today : Breaking News, Live Updates & Top Stories | Vimarsana

(2) NOT FOR DISTRIBUTION IN OR INTO OR TO ANY PERSON LOCATED OR RESIDENT IN THE UNITED STATES, ITS TERRITORIES AND POSSESSIONS (INCLUDING PUERTO RICO, THE U.S. VIRGIN ISLANDS, GUAM, AMERICAN SAMOA, WAKE ISLAND AND THE NORTHERN MARIANA ISLANDS, ANY STATE OF THE UNITED STATES AND THE DISTRICT OF COLUMBIA) OR TO ANY U.S. PERSON (AS DEFINED IN REGULATION S OF THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED) OR IN ANY JURISDICTION WHERE IT IS UNLAWFUL TO RELEASE, PUBLISH OR DISTRIBUTE THIS DOCUMENT. THE DISTRIBUTION OF THIS DOCUMENT IN CERTAIN JURISDICTIONS (IN PARTICULAR, THE UNITED STATES A...

Turkiye Garanti Bankasi A.S.: Prospectus - Issuer Information Document DJ Turkiye Garanti Bankasi A.S.: Prospectus - Issuer Information Document Turkiye Garanti Bankasi A.S. (TGBD) Turkiye Garanti Bankasi A.S.: Prospectus - Issuer Information Document 30-Dec-2020 / 13:01 GMT/BST Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement. TO: Investment Community FROM: Garanti BBVA / Investor Relations ........................................ SUBJECT: Prospectus - Issuer Information Document ...

(3) Reference is made to section 6.8 "Shareholdings and stock options" of the Information Document for Hexagon Purus AS ("the Company" or "Hexagon Purus"), published on Friday 11 December, and prepared in relation to the listing of Hexagon Purus on Euronext Growth Oslo. Hexagon Purus' management investment program with PSU matching aims to align the objectives of shareholders and key employees in order to increase the value of the company in the long term. Key members of Hexagon Purus' management team have exercised their right to purchase the maximum number of shares allowable in the managem...

Onxeo S.A.: Onxeo Announces the Transfer of the Listing of its Shares to Euronext Growth Paris on December 15, 2020 Onxeo" or " the Company"), a clinical-stage biotechnology company specializing in the development of innovative drugs targeting tumor DNA Damage response (DDR), in particular against rare or resistant cancers, announced the transfer of the listing of its shares from the Euronext Paris regulated market (compartment C) to the Euronext Growth Paris multilateral trading facility on December 15, 2020. The application for the admission of Onxeo's shares to the Euronext Growth market i...

Links including into the president? that was in the formation document. is that the answer? >> yes, absolutely. what comey said was this was a counter intelligence investigation and it involved collusion and coordination, et cetera. also we learned from the new york times in that story that said that the fbi was looking at the president as a possible asset that they also believed that it was a criminal investigation worth opening. so they opened simultaneously a criminal and counter intelligence investigation and whether he believes that he engaged in such corosive actions.